NORTHERN TRUST CORP – Regeneron Pharmaceuticals, Inc. Transaction History
NORTHERN TRUST CORP portfolio value:
$818.92M
portfolio value
NORTHERN TRUST CORP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.86% | -10.36K shares | 110.06M | $688.87 | 1.18M |
Q2 2022 | share | Decrease | -0.16% | -1.95K shares | -130.02M | $591.13 | 1.19M |
Q1 2022 | share | Decrease | -0.18% | -2.21K shares | 78.95M | $698.42 | 1.20M |
Q4 2021 | share | Increase | +0.27% | 3.29K shares | 33.68M | $642.51 | 1.20M |
Q3 2021 | share | Increase | +3.32% | 38.53K shares | 77.49M | $605.18 | 1.20M |
Q2 2021 | share | Decrease | -1.32% | -15.58K shares | 91.81M | $558.54 | 1.16M |
Q1 2021 | share | Decrease | -5.30% | -65.88K shares | -43.56M | $473.14 | 1.17M |
Q4 2020 | share | Decrease | -3.40% | -43.72K shares | -119.77M | $483.11 | 1.24M |
Q3 2020 | share | Increase | +5.02% | 61.53K shares | -43.80M | $559.78 | 1.28M |
Q2 2020 | share | Increase | +27.48% | 264.12K shares | 294.80M | $623.65 | 1.22M |
Q1 2020 | share | Increase | +1.53% | 14.44K shares | 113.84M | $488.29 | 961.04K |
Q4 2019 | share | Increase | +0.51% | 4.77K shares | 94.16M | $375.48 | 946.59K |
Q3 2019 | share | Decrease | -3.75% | -36.69K shares | -45.01M | $277.4 | 941.82K |
Q2 2019 | share | Increase | +0.57% | 5.53K shares | -93.25M | $313 | 978.51K |
Q1 2019 | share | Increase | +2.12% | 20.21K shares | 43.66M | $410.62 | 972.98K |
Q4 2018 | share | Increase | +2.42% | 22.46K shares | -20.01M | $373.5 | 952.77K |
Q3 2018 | share | Decrease | -0.42% | -3.94K shares | 53.57M | $404.04 | 930.30K |
Q2 2018 | share | Increase | +1.96% | 17.93K shares | 6.76M | $344.99 | 934.24K |
Q1 2018 | share | Decrease | -2.02% | -18.89K shares | -36.06M | $344.36 | 916.31K |
Q4 2017 | share | Decrease | -2.37% | -22.75K shares | -76.72M | $375.96 | 935.20K |
Q3 2017 | share | Increase | +2.86% | 26.67K shares | -29.06M | $447.12 | 957.96K |
Q2 2017 | share | Increase | +0.75% | 6.97K shares | 99.21M | $491.14 | 931.28K |
Q1 2017 | share | Increase | +3.29% | 29.48K shares | 29.69M | $387.51 | 924.30K |
Q4 2016 | share | Decrease | -3.13% | -28.86K shares | -42.86M | $367.09 | 894.82K |
Q3 2016 | share | Increase | +0.02% | 157 shares | 48.81M | $402.02 | 923.68K |
Q2 2016 | share | Decrease | -0.01% | -105 shares | -15.68M | $349.23 | 923.53K |
Q1 2016 | share | Decrease | -0.35% | -3.24K shares | -164.96M | $360.44 | 923.63K |